One pill to tackle two heart risks: triple combo shows promise

NCT ID NCT03860220

First seen May 05, 2026 · Last updated May 08, 2026 · Updated 1 time

Summary

This study tested a single pill containing three medicines (telmisartan, amlodipine, and rosuvastatin) in 252 Korean adults with both high blood pressure and high cholesterol. After 8 weeks, the pill lowered blood pressure and LDL (bad) cholesterol. The goal was to see if combining treatments is safe and effective for managing these two common conditions together.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHA Bundang Medical Center, CHA University

    Seongnam-si, Gyeonggi-do, 13496, South Korea

  • Hallym University Kangnam Sacred Heart Hospital

    Seoul, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang-si, Gyeonggi-do, 14068, South Korea

  • Kangwon National University Hospital

    Chuncheon, Gangwon-do, 24289, South Korea

  • Korea University Ansan Hospital

    Ansan, Gyeonggi-do, 15355, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, 03722, South Korea

  • Yeungnam University Hospital

    Daegu, 42415, South Korea

  • Yonsei University Wonju Severance Christian Hospital

    Wŏnju, South Korea

Conditions

Explore the condition pages connected to this study.